Floatz logo

cc-5013

Renal Failure

Hellenic Society of HematologyPhase 2Active
B
62/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
47/ 100
Competitive Position
89/ 100

Competitive context

19 Active assets in the Renal Failure cohort.

Asset / SponsorPhaseRating
NORMAL HUMAN SERUM ALBUMIN
Anna Cruceta
Phase 4BBB
Midodrine
Anna Cruceta
Phase 4BB
DEXAMETHASONE
Augusta University
Phase 3BB
Envarsus Product
University of Alberta
Phase 4BB
TENOFOVIR DISOPROXIL FUMARATE
Thomas Benfield
Phase 4BB

View all 50 →

Same molecule, other indications

cc-5013 is also rated in:

B-cell non-Hodgkin lymphomaDormant
BBB
Indicative ·
75 / 100
View asset →
Recurrent Adult Hodgkin LymphomaDormant
BBB
Indicative ·
74 / 100
View asset →
adult T-cell leukemia/lymphomaDormant
BBB
Indicative ·
74 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →